Home Publications Research Grants Inventions & Patents Awards Additional Research Activities Faculties & Institutions Research Areas

Early recognition of lung cancer by integrin targeted imaging in K-ras mouse model

Ermolayev V, Mohajerani P, Ale A, Sarantopoulos A, Aichler M, Kayser G, Walch A, Ntziachristos V (2015)

---

Publication Type: Journal article

Publication year: 2015

Journal

Book Volume: 137

Pages Range: 1107-1118

Journal Issue: 5

DOI: 10.1002/ijc.29372

Abstract

Non-small cell lung cancer is characterized by slow progression and high heterogeneity of tumors. Integrins play an important role in lung cancer development and metastasis and were suggested as a tumor marker; however their role in anticancer therapy remains controversial. In this work, we demonstrate the potential of integrin-targeted imaging to recognize early lesions in transgenic mouse model of lung cancer based on spontaneous introduction of mutated human gene bearing K-ras mutation. We conducted ex vivo and fluorescence molecular tomography-X-ray computed tomography (FMT-XCT) in vivo imaging and analysis for specific targeting of early lung lesions and tumors in rodent preclinical model for lung cancer. The lesions and tumors were characterized by histology, immunofluorescence and immunohistochemistry using a panel of cancer markers. Ex vivo, the integrin-targeted fluorescent signal significantly differed between wild type lung tissue and K-ras pulmonary lesions (PL) at all ages studied. The panel of immunofluorescence experiments demonstrated that PL, which only partially show cancer cell features were detected by αvβ3-integrin targeted imaging. Human patient material analysis confirmed the specificity of target localization in different lung cancer types. Most importantly, small tumors in the lungs of 4-week-old animals could be noninvasively detected in vivo on the fluorescence channel of FMT-XCT. Our findings demonstrated αvβ3-integrin targeted fluorescent imaging to specifically detect premalignant pleural lesions in K-ras mice. Integrin targeted imaging may find application areas in preclinical research and clinical practice, such as early lung cancer diagnostics, intraoperative assistance or therapy monitoring. What's new? Integrins play an important role in lung-cancer development and metastasis, and these molecules might therefore be useful as tumor biomarkers. In this study, the authors found that targeted imaging of αvβ3-integrin may allow preclinical researchers and clinicians to detect non-small cell lung cancer (NSCLC) at an earlier stage than accepted cancer markers. This approach may also enhance monitoring of anticancer therapies in early lung cancer.

Involved external institutions

How to cite

APA:

Ermolayev, V., Mohajerani, P., Ale, A., Sarantopoulos, A., Aichler, M., Kayser, G.,... Ntziachristos, V. (2015). Early recognition of lung cancer by integrin targeted imaging in K-ras mouse model. International Journal of Cancer, 137(5), 1107-1118. https://dx.doi.org/10.1002/ijc.29372

MLA:

Ermolayev, Vladimir, et al. "Early recognition of lung cancer by integrin targeted imaging in K-ras mouse model." International Journal of Cancer 137.5 (2015): 1107-1118.

BibTeX: Download